Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers
- 31 March 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 173 (3) , 165-168
- https://doi.org/10.1016/s0002-9610(97)89589-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Quick healing of leg ulcers after molgramostimThe Lancet, 1994
- Treatment of non-healing ulcers with rhGM-CSF and skin graftsThe Lancet, 1994
- Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcomaThe Lancet, 1993
- Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.The Journal of Experimental Medicine, 1992
- Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growthPublished by Elsevier ,1991
- Angiogenesis in wound healingPharmacology & Therapeutics, 1991
- Granulocyte-Macrophage Colony-Stimulating Factor: Pleiotropic Cytokine with Potential Clinical UsefulnessClinical Infectious Diseases, 1990
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.The Journal of Experimental Medicine, 1987
- Cutaneous tissue repair: Basic biologic considerations. IJournal of the American Academy of Dermatology, 1985